课题基金 / 基金详情

NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE

NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE
NIAID 流感研究和应对卓越中心
批准号：
10621126
负责人：
RICHARD WEBBY
金额：
$637.95万
依托单位：
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
项目状态：
已结题
起止时间：
2021-04-01 至 2024-07-14
来源：
https://reporter.nih.gov/project-details/10621126
关键词：
AnimalsAvian InfluenzaBasic ScienceCohort StudiesDisease OutcomeEnvironmental Risk FactorEvolutionHumanImmuneImmune responseImmunologic FactorsInfluenzaInfluenza A virusInfluenza B VirusInfluenza vaccinationMolecularNational Institute of Allergy and Infectious DiseasePathogenicityResearchSamplingVaccinationcross immunityimprovedinfluenza infectioninfluenzavirusresponsetransmission processvaccine trial

项目摘要

项目成果

RICHARD WEBBY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
CEIRR will determine the molecular, ecologic and/or environmental factors that influence the evolution, emergence, transmission and pathogenicity of influenza viruses, and characterize the immune response to influenza infection to improve understanding of the immune correlates of protection and cross-protection. CEIRR will carry out a host of activities, including cohort studies and human and animal sampling to further understanding of influenza infection, transmission and vaccination; identification of immunological factors that determine disease outcome in the response to influenza infection and vaccination; and studies to determine how influenza viruses evolve, adapt and transmit between humans and at interspecies interfaces.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CEIRR: SARS-CoV-2 Research Activities
CEIRR: SARS-CoV-2 Research Activities
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE
CEIRR: SARS-CoV-2 Research Activities
海外基金